Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for researching interaction between drug and blood albumen and special micro-fluidic chip thereof

A microfluidic chip, drug technology, applied in testing pharmaceutical preparations, biological testing, material inspection products, etc., can solve problems such as poor repeatability

Inactive Publication Date: 2012-12-12
DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But the reproducibility of the method is not very good

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for researching interaction between drug and blood albumen and special micro-fluidic chip thereof
  • Method for researching interaction between drug and blood albumen and special micro-fluidic chip thereof
  • Method for researching interaction between drug and blood albumen and special micro-fluidic chip thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Heparin is a highly sulfated linear polysaccharide. Heparin has a variety of biological activities, such as anticoagulant, anti-inflammatory, antiviral, antithrombotic and antilipidemia. Heparin is mainly used clinically as an anticoagulant, and can also be used as an antithrombotic and antilipidemia. This example mainly studies the interaction between heparin and serum proteins. Rhodamine B was used as the reference substance. The glass chip used had microchannels with a width of 50 microns and a depth of 15 microns. Rhodamine B, human serum albumin (1.36-21.77μM), human serum albumin and different concentrations of heparin mixture (21.77μM human serum albumin and 125.49, 250.98, 376.50, 501.96, and 627.45μM heparin) were respectively Put into the sample cells of the first, second and third units. Apply voltage to the sample pool and waste liquid pool of the first unit, and maintain the field strength at 300V / cm. After 19s of sampling, apply voltage to the buffer p...

Embodiment 2

[0027] This example is similar to Example 1, and also studies the interaction between heparin and serum proteins. The difference is that:

[0028] 1. The size of the microchannels of the glass chip used is different, the width is 70 microns, and the depth is 20 microns.

[0029] 2. The injection field strength is 500V / cm, and the injection time is 11s.

[0030] 3. The separation field strength is 800V / cm.

[0031] The experimental phenomena observed in this example are consistent with those in Example 1, and the measured values ​​of binding constants and binding sites are also consistent with those measured in Example 1. However, because a higher field strength than in Example 1 was used, the time of the entire measurement process was shortened to 11 minutes.

Embodiment 3

[0033]Porphyrins are clinically used as photosensitizers for photodynamic therapy of cancer. Studies have shown that serum albumin can be used as an endogenous carrier of porphyrin to achieve photodynamic therapy of cancer. In order to deepen the understanding of the mechanism of action, the interaction constant between porphyrin and serum albumin is undoubtedly a very important parameter. This example investigates the interaction between porphyrin and human serum albumin. The glass chip used had microchannels with a width of 60 microns and a depth of 18 microns. Except adopting sodium fluorescein as the reference substance and changing the injection time to 5s, other operations were similar to Example 1. Figure 4 , 5 Experimental results are given. From Figure 5 , it can be seen that with the increase of porphyrin concentration, the peak of serum albumin gradually decreased. This indicates a binding reaction between porphyrin and serum albumin. The obtained binding c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
depthaaaaaaaaaa
Login to View More

Abstract

The invention relates to a multifunctional microflow controlled chip for researching the interaction of the serum protein and drug, composed of three units. The upstream end of the separate channel of each unit is connected with the downstream end of the prior unit. The researching process comprises: respectively putting the primacy standard substance, the detected objects of different concentration, the solution of drug and protein proportionally mixed into the sample cells of the first, second, third unit; the samples in each sample cell being subjected to the electrophoresis operation in turn such as sampling, separating or the like; calibrating the detection signal by the primacy standard substance and drafting the work curve based on the data of the second unit and acquiring the binding constant and binding site number based on the third unit. One on-line analysis in split second can be performed on the plastic or glass plate etched with a micro-channel of width and depth at the range of 10-100mircro, and the research of the interaction of the drug and protein can be completed. The total experiment can be completed in several minutes and the sample consumption is of microlitre grade. In addition, the invention has high sensitivity and low detection limit.

Description

Technical field: [0001] The invention relates to drug screening technology, and in particular provides a method for studying the interaction between drugs and serum proteins and a special microfluidic chip. Background technique [0002] Most of the drugs that enter the blood will undergo a reversible binding reaction with serum proteins. This combination reaction greatly affects the properties of drug delivery, distribution, metabolism, and excretion in the body. More importantly, this response directly determines the therapeutic effect of the drug, because only the free drug can exert pharmacological effects. Only when the free concentration of the drug is controlled within an appropriate range can an ideal therapeutic effect be achieved. If the binding ratio of the drug to serum protein is relatively high, it will not only reduce the effective concentration of the drug, inhibit the curative effect of the drug, but also prolong the half-life of the drug and enhance the to...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N33/68G01N33/15
Inventor 秦建华刘晓君戴忠鹏林炳承
Owner DALIAN INST OF CHEM PHYSICS CHINESE ACAD OF SCI